Evaluation of Ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis

BACKGROUND: To avert nausea and vomiting the 5-Hydroxytryptamine3 (5-HT3) antagonists have become the first line of treatment ifassociated with cardiovascular effects andappear to cause QT prolongation. OBJECTIVE: Evaluate the effect of 1 mg, 4 mg, and 8 mg bolus doses of intravenous Ondansetron, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Sampa Dutta, Pal, Ranabir, Sarkar, Aniruddha, Mukherjee, Sudakshina, Mitra, Koel, Roy, Suddhadeb, Sarbapalli, Debabrata, Kundu, Kanak Kanti, Zaman, Forhad Akhtar, Kar, Sumit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312691/
https://www.ncbi.nlm.nih.gov/pubmed/22470245
http://dx.doi.org/10.4103/0976-9668.82306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312691/
https://www.ncbi.nlm.nih.gov/pubmed/22470245
http://dx.doi.org/10.4103/0976-9668.82306

Ejemplares similares